BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 34398954)

  • 1. Changing Epidemiology of Hepatitis B Virus and Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus-Positive Population in China: Results From the Third and Fourth Nationwide Molecular Epidemiologic Surveys.
    Liu L; Wang L; Zhang H; Ou W; Li D; Feng Y; Zhuang H; Shao Y
    Clin Infect Dis; 2021 Aug; 73(4):642-649. PubMed ID: 34398954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
    Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
    Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study.
    Jia J; Zhu Q; Deng L; Lan G; Johnson A; Chen H; Shen Z; Li J; Xing H; Ruan Y; Li J; Lu H; Vermund SH; Zhu J; Qian HZ
    Infect Dis Poverty; 2022 Jan; 11(1):7. PubMed ID: 34986877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey.
    Weitzel T; Rodríguez F; Noriega LM; Marcotti A; Duran L; Palavecino C; Porte L; Aguilera X; Wolff M; Cortes CP
    PLoS One; 2020; 15(1):e0227776. PubMed ID: 31917810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.
    Kenfack-Momo R; Kenmoe S; Takuissu GR; Ebogo-Belobo JT; Kengne-Ndé C; Mbaga DS; Tchatchouang S; Oyono MG; Kenfack-Zanguim J; Lontuo Fogang R; Mbongue Mikangue CA; Zeuko'o Menkem E; Ndzie Ondigui JL; Kame-Ngasse GI; Magoudjou-Pekam JN; Taya-Fokou JB; Bowo-Ngandji A; Nkie Esemu S; Kamdem Thiomo D; Moundipa Fewou P; Ndip L; Njouom R
    PLoS One; 2022; 17(5):e0269250. PubMed ID: 35639675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
    Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
    J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
    Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009.
    Zhou S; Zhao Y; He Y; Li H; Bulterys M; Sun X; Dou Z; Robinson M; Zhang F
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):191-6. PubMed ID: 20032784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia.
    Hagos YM; Yalew GT; Meles HN; Tsegay E; Lemelem M; Wasihun AG
    PLoS One; 2024; 19(5):e0302453. PubMed ID: 38753600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
    Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
    PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sero-prevalence of hepatitis B virus and hepatitis C virus among HIV patients in a suburban University Teaching Hospital in South-East Nigeria.
    Diwe CK; Okwara EC; Enwere OO; Azike JE; Nwaimo NC
    Pan Afr Med J; 2013; 16():7. PubMed ID: 24570778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
    Al-Mughales JA
    J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and C viral coinfections and their association with HIV viral load suppression among HIV-1 infected patients on ART at Mekelle hospital, northern Ethiopia.
    Teame G; Gebreyesus A; Tsegay E; Gebretsadik M; Adane K
    AIDS Res Ther; 2022 Dec; 19(1):57. PubMed ID: 36457041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
    Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
    Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
    Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
    BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.